EUVIMEDEUVIMED entdecken
Open Access

Transcriptomic analyses of human brains with Alzheimer’s disease identified dysregulated epilepsy-causing genes

Abdallah M Eteleeb, Suélen Santos Alves, Stephanie Buss, Mouhsin Shafi, Daniel Press, Norberto Garcia-Cairasco, Bruno A Benitez

Epilepsy & Behavior · 2025

DOI: 10.1016/j.yebeh.2025.110421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior, 2025. Verfasst von Abdallah M Eteleeb und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Washington University, Saint Louis, St. Louis, MO, United States of America; The Charles F. and Joanne Knight Alzheimer Dis…. Hauptthemen laut MEDLINE: Alzheimer Disease, Epilepsy, Brain, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & OBJECTIVE: Alzheimer's Disease (AD) patients at multiple stages of disease progression have a high prevalence of seizures. However, whether AD and epilepsy share pathophysiological changes remains poorly defined. In this study, we leveraged high-throughput transcriptomic data from sporadic AD cases at different stages of cognitive impairment across multiple independent cohorts and brain regions to examine the role of epilepsy-causing genes. METHODS: Epilepsy-causing genes were manually curated, and their expression levels were analyzed across bulk transcriptomic data from three AD cohorts and three brain regions. RNA-seq data from sporadic AD and control cases from the Knight ADRC, MSBB, and ROSMAP cohorts were processed and analyzed under the same analytical pipeline. An integrative clustering approach employing machine learning and multi-omics data was employed to identify molecularly defined profiles with different cognitive scores. RESULTS: We found several epilepsy-associated genes/pathways significantly dysregulated in a group of AD patients with more severe cognitive impairment. We observed 15 genes consistently downregulated across the three cohorts, including sodium and potassium channels genes, suggesting that these genes play fundamental roles in cognitive function or AD progression. Notably, we found 25 of these genes dysregulated in earlier stages of AD and become worse with AD progression. CONCLUSION: Our findings revealed that epilepsy-causing genes showed changes in the early and late stages of AD progression, suggesting that they might be playing a role in AD progression. We can not establish directionality or cause-effect with our findings. However, changes in the epilepsy-causing genes might underlie the presence of seizures in AD patients, which might be present before or concurrently with the initial stages of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseEpilepsyBrainTranscriptomeHumansMaleFemaleAgedGene Expression ProfilingCognitive DysfunctionCohort StudiesAged, 80 and overDisease Progression

Stichwörter der Autor:innen

Alzheimer diseaseBrainEpilepsyMulti-omicsSynaptopathyTranscriptomics

Autor:innen und Institutionen

  • Department of Psychiatry, Washington University, Saint Louis, St. Louis, MO, United States of America; The Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University, St. Louis, MO, United Sta…
  • Department of Neurosciences and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), Brazil.
  • Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America.
  • Department of Neurosciences and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), Brazil; Department of Physiology, Ribeirão Preto Medical School - University of São Paulo (FMRP-USP…
  • Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America. Electronic address: bbenitez@bidmc.harvard.edu.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • National Institute on Aging
  • National Institute of Neurological Disorders and Stroke
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Universidade de São Paulo
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Eteleeb, A. M., Alves, S. S., Buss, S., Shafi, M., Press, D., Garcia-Cairasco, N., & Benitez, B. A. (2025). Transcriptomic analyses of human brains with Alzheimer’s disease identified dysregulated epilepsy-causing genes. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2025.110421

Vancouver

Eteleeb AM, Alves SS, Buss S, Shafi M, Press D, Garcia-Cairasco N, et al. Transcriptomic analyses of human brains with Alzheimer’s disease identified dysregulated epilepsy-causing genes. Epilepsy & Behavior. 2025. doi:10.1016/j.yebeh.2025.110421

BibTeX
@article{Eteleeb2025,
  author = {Eteleeb, Abdallah M and Alves, Suélen Santos and Buss, Stephanie and Shafi, Mouhsin and Press, Daniel and Garcia-Cairasco, Norberto and Benitez, Bruno A},
  title = {Transcriptomic analyses of human brains with Alzheimer’s disease identified dysregulated epilepsy-causing genes},
  journal = {Epilepsy & Behavior},
  year = {2025},
  doi = {10.1016/j.yebeh.2025.110421}
}
Kostenlos starten →